Allergic manifestations of human immunodeficiency virus (HIV) infection (Q41158781)

27 September 2017

title

Allergic manifestations of human immunodeficiency virus (HIV) infection (English)

1 reference

27 September 2017

A Carr

1

1 reference

27 September 2017

D A Cooper

series ordinal

2

1 reference

27 September 2017

R Penny

series ordinal

3

1 reference

27 September 2017

publication date

1 March 1991

1 reference

Journal of Clinical Immunology

27 September 2017

published in

1 reference

27 September 2017

volume

11

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

55-64

1 reference

Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Pulmonary infiltrates and hypoxemia in patients with the acquired immunodeficiency syndrome re-exposed to trimethoprim-sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Hypersensitivity reactions to ampicillin in cytomegalovirus mononucleosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF00917741

Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma

21 January 2018

1 reference

12 December 2020

Trimethoprim-Sulfamethoxazole Treatment ofPneumocystis cariniiPneumonia in Adults

1 reference

12 December 2020

IgE-binding factors and regulation of the IgE antibody response

1 reference

12 December 2020

Phenytoin hypersensitivity with pulmonary involvement in a hemophiliac patient with human immunodeficiency virus infection

1 reference

12 December 2020

Fatal toxic epidermal necrolysis during prophylaxis with pyrimethamine and sulfadoxine in a human immunodeficiency virus-infected person

1 reference

12 December 2020

Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome

1 reference

12 December 2020

Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis

1 reference

12 December 2020

Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions

1 reference

12 December 2020

Multiple drug reactions in a patient with AIDS

1 reference

12 December 2020

An immunoassay for the detection of IgE antibodies to trimethoprim in the sera of allergic patients

1 reference

12 December 2020

Histamine release from basophil leukocytes induced by microbial antigen preparations in patients with AIDS

1 reference

12 December 2020

Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia

1 reference

12 December 2020

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

1 reference

12 December 2020

IgE in immunodeficiency

1 reference

12 December 2020

Zidovudine-induced fever

1 reference

12 December 2020

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy

1 reference

12 December 2020

Chronic diffuse dermatitis and hyper-IgE in HIV infection

1 reference

12 December 2020

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

1 reference

12 December 2020

Management of drug allergy in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Differential regulation of IgG1 and IgE synthesis by interleukin 4.

1 reference

12 December 2020

Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma

1 reference

12 December 2020

Hyperproduction of IgE and T-cell dysfunction in Hodgkin's disease

1 reference

12 December 2020

Treatment of Pneumocystis carinii pneumonia with trimetrexate in acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Excess of ampicillin rashes associated with allopurinol or hyperuricemia. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

1 reference

12 December 2020

Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS.

1 reference

12 December 2020

IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma

1 reference

12 December 2020

Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients

1 reference

12 December 2020

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

1 reference

12 December 2020

Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole

1 reference

12 December 2020

Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy

1 reference

12 December 2020

Anaphylaxis to flucytosine in a patient with AIDS

1 reference

12 December 2020

NHLBI workshop summary. Pulmonary complications of the acquired immunodeficiency syndrome: an update. Report of the second National Heart, Lung and Blood Institute workshop

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

1 reference

12 December 2020

Serum IgD and IgE concentrations in immunodeficiency diseases

1 reference

12 December 2020

Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis

1 reference

12 December 2020

Ampicillin hypersensitivity in lymphatic leukaemia.

1 reference

12 December 2020

Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites

1 reference

12 December 2020

Hypersensitivity reactions to drugs in acquired immunodeficiency syndrome

1 reference

12 December 2020

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

1 reference

12 December 2020

LAV/HTLV-III infection and atopy: serum IgE and specific IgE antibodies to environmental allergens

1 reference

12 December 2020

Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation

1 reference

12 December 2020

HIV antigen stimulates basophil leukocytes from AIDS patients to release histamine due to type I allergy

1 reference

12 December 2020

Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone

1 reference

12 December 2020

Sulphadiazine desensitisation in AIDS patients

1 reference

12 December 2020

The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction

1 reference

12 December 2020

Type I reactions directed against Pneumocystis carinii in AIDS patients

1 reference

12 December 2020

Role of interleukins in induction and regulation of human IgE synthesis

1 reference

12 December 2020

Rash with amoxycillin-clavulanate therapy in HIV-infected patients

1 reference

12 December 2020

Serum IgE and human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men

1 reference

12 December 2020

Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00917741

1 reference

Dimensions Publication ID

27 September 2017

1039902689

0 references

1 reference